{
  "ticker": "RGT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967107",
  "id": "02967107",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250708",
  "time": "0926",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06ll350bd54grs.pdf",
  "summary": "### Summary of ASX Announcement:  \n\n- **Key Milestone Achieved**: Argent BioPharma (ASX: RGT) has commenced **EU-GMP cannabinoid API supply** to University Medical Centre Ljubljana (Slovenia's largest hospital) for **epilepsy treatment**, following a successful pilot.  \n- **Commercial Expansion**: Builds on **CannEpil\u00ae\u2019s EU market presence**, demonstrating regulatory and clinical acceptance in **refractory epilepsy**.  \n- **Regulatory Leadership**: Collaboration with **Slovenian health authorities** (Ministry of Health, JAZMP) helped establish **national framework** for hospital-compounded cannabinoid therapies.  \n- **Strategic Impact**: Validates **conversion of pilot programs into commercial supply**, supporting further **EU and U.S. expansion plans**.  \n\nNo capital raising, financials, or specific trading-sensitive dates disclosed. Operational update with **positive commercial/regulatory implications**.  \n\n*(Note: No material financial or liquidity-impacting data provided; primarily a business development announcement.)*",
  "usage": {
    "prompt_tokens": 1514,
    "completion_tokens": 216,
    "total_tokens": 1730,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-07T23:53:31.265024"
}